© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Trogarzo
FDA Approves Antibody Treatment Trogarzo for Multidrug-Resistant HIV
Trogarzo (ibalizumab-uiyk) 101
Chart of Approved and Experimental HIV Medications

Trogarzo Bests Highly Resistant HIV

Expanded access study confirms the long-acting monoclonal antibody works well in people with extensive prior treatment.
Antibodies

Trogarzo Again Shown Effective Against Highly Resistant HIV

Expanded access study confirms the long-acting monoclonal antibody works well in people with extensive prior treatment.

Treatment: Trogarzo Durability

A clinical trial has confirmed that new HIV treatment Trogarzo suppresses one’s viral load.

CROI 2019: So Much More Than an HIV Cure Extravaganza

The Conference on Retroviruses and Opportunistic Infections in Seattle saw many important studies that are advancing the fight against HIV.

Trogarzo’s Effects on Hard-to-Treat HIV Are Stable Over Two Years

Researchers followed a small group of people with highly drug-resistant virus taking injectable antibody.

Trogarzo Can Beat Drug Resistance

Researchers gave the antibody treatment to those with multidrug-resistant HIV along with an optimized antiretroviral regimen.

Trogarzo Can Keep Viral Load Suppressed for at Least a Year

Researchers gave the antibody treatment to those with multidrug-resistant HIV along with an optimized antiretroviral regimen.
Nelson Vergel

Built to Survive

Nelson Vergel pushes for the development of new salvage therapies.

New Salvage Treatment

The Food and Drug Administration approves antibody treatment Trogarzo for multidrug-resistant HIV.

Long-Acting Antibody Treatment for Resistant HIV Continues to Show Promise

With an FDA decision for ibalizumab pending, data about a group with multidrug resistance show that the antibody is effective.

Treatment: Antibody Treatment

TaiMed Biologics has applied for approval of the weekly injectable antibody ibalizumab for people with multidrug-resistant virus.

First Antibody Treatment for Drug-Resistant HIV May Get FDA Nod

TaiMed Biologics has applied for approval of the weekly injectable antibody ibalizumab for those with multidrug-resistant virus.
Advertisement
Treatment News
Features